2,024
Views
72
CrossRef citations to date
0
Altmetric
Research Articles

4-vinylcyclohexene diepoxide: a model chemical for ovotoxicity

&
Pages 57-62 | Received 16 Sep 2011, Accepted 30 Nov 2011, Published online: 12 Jan 2012

References

  • Borman, S.M., VanDePol, B.J., Kao, S., Thompson, K.E., Sipes, I.G. and Hoyer, P.B. (1999) A single dose of the ovotoxicant 4-vinylcyclohexene diepoxide is protective in rat primary ovarian follicles. Toxicol Appl Pharmacol 158:244–252.
  • Borman, S.M., Christian, P.J., Sipes, I.G. and Hoyer, P.B. (2000) Ovotoxicity in female Fischer rats and B6 mice induced by low-dose exposure to three polycyclic aromatic hydrocarons: Comparison through calculation of an ovotoxic index. Toxicol Appl Pharmacol 167:191–198.
  • Cannady, E.A., Dyer, C.A., Christian, P.J., Sipes,I.G. and Hoyer, P.B. (2002) Expression and activity of microsomal epoxide hydrolase in follicles isolated from mouse ovaries. Toxicol Sci 68:24–31.
  • Cannady, E.A., Dyer, C.A., Christian, P.J., Sipes, I.G. and Hoyer, P.B. (2003) Expression and activity of cytochromes P450 2E1, 2A, and 2B in the mouse ovary: the effect of 4-vinylcyclohexene and its diepoxide metabolite. Toxicol Sci 73:423–430.
  • Carlsson, I., Laitinen, M.P., Scott, J., Louhio, H., Velentzis, L., Tuuri, T., (2006) Kit ligand and c-kit are expressed during early human ovarian follicular development and their interaction is required for the survival of follicles in long-term culture. Reprod 131:641–649.
  • Carr, M.C. (2003) The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metabol 88:2404–2411.
  • Chapman, R.M. (1983) Gonadal injury resulting from chemotherapy. Am J Ind Med 4:149–161.
  • Damewood, M.D. and Grochow, L.B. (1986) Prospects for fertility after chemotherapy or radiation for neoplastic disease. Fertil Steril 45:443–459.
  • Devine, P.J., Sipes, I.G., Skinner, M.K. and Hoyer, P.B. (2002) Characterization of a rat in vitro ovarian culture system to study the ovarian toxicant 4-vinylcyclohexene diepoxide. Toxicol Appl Pharmacol 184:107–115.
  • Doerr, J.K., Hooser, S.B., Smith, B.J. and Sipes, I.G. (1995) Ovarian toxicity of 4-vinylcyclohexene and related olefins in B6C3F1 mice: Role of diepoxides. Chem Res Toxicol 8:963–969.
  • Everson, B.R., Sandler, D.P., Wilcox, A.J., Schreinemachhers, D., Shore, D.L. and Weinberg, C.R. (1986) Effect of passive exposure to smoking in age at natural menopause. Br Med J 293:792.
  • Fernandez, E., LaVecchia, C., Braga, C., Talamini, R., Negri, E., Prazzini, F. and Franceschi, S. (1998) Hormone replacement therapy and risk of colon and rectal cancer. Cancer Epidemiol Viomarkers Prev 7:329–333.
  • Fernandez, S.M., Keating, A.F., Christian, P.J., Sen, N., Hoying, J.B., Brooks, H.L., (2008) Involvement of the KIT//KITLG signaling pathway in 4-vinylcyclohexene diepoxide-induced ovarian follicle loss in rats. Biol Reprod 79:318–327.
  • Flaws, J.A., Salyers, K.L., Sipes, I.G. and Hoyer, P.B. (1994) Reduced ability of rat pre-antral follicles to metabolize 4-vinylcyclohexene diepoxide. Toxicol Appl Phrmacol 126:286–294.
  • Hooser, S.B., Douds, D.A., Hoyer, P.B. and Sipes, I.G. (1994) Long-term ovarian and hormonal alterations due to the ovotoxin 4-vinylcyclohexene. Reprod Toxciol 8:315–323.
  • Hoyer, P.B. and Devine, P.J. (2002) Endocrine toxicology: The female reproductive system. In Handbook of Toxicology 2nd Edition ed.Derelanko M.J., CRC Press FL USA ppp.573–595.
  • Hoyer, P.B. and Sipes, I.G. (2007) Development of an animal model for ovotoxicity using 4-vinylcyclohexene: a case study. Birth Defects Res B Dev Reprod Toxicol 80:113–125.
  • Hu, X., Christian, P.J., Sipes, I.G. and Hoyer, P.B. (2001a) Expression and redistribution of cellular bad, bax and bcl-xl protein is associated with VCD-induced ovotoxicity in rats. Biol Reprod 65:1489–1495.
  • Hu, X., Christian, P.J., Thompson, K.E., Sipes, I.G. and Hoyer, P.B. (2001b) Apoptosis induced in rats by 4-vinylcyclohexene diepoxide is associated with activation of the caspase cascades. Biol Reprod 65:87–93.
  • Hu, X., Flaws, J.A., Sipes, I.G. and Hoyer, P.B. (2002) Activation of mitogen-activated protein kinases and AP-1 transcription factor in ovotoxicity induced by 4-vinylcyclohexene diepoxide in rats. Biol Reprod 67:718–724.
  • Huff, J. (2001) Carcinogenicity bioassays of bisphenol A, 4-vinylcyclohexene diepoxide, and 4-vinylcyclohexene. Toxicol Sci 64:282–283.
  • Jin, X., Han, C.S., Yu, F.Q., Wei, P., Hu, Z.Y. and Liu Y.X. (2005) Anti-apoptotic action of stem cell factor on oocytes in primordial follicles and its signal transduction. Mol Reprod Dev 70:82–90.
  • Kao, S., Sipes, I.G. and Hoyer, P.B. (1999) Early effects of ovotoxicity induced by 4-vinylcyclohexene diepoxide in rats and mice. Reprod Toxicol 13:67–75.
  • Keating, A.F., Sipes, I.G. and Hoyer, P.B. (2008a) Expression of ovarian microsomal epoxide hydrolase and glutathione-S-transferase during onset of VCD-induced ovotoxicity in B6C3F1 mice. Toxicol Appl Pharmacol 230:109–116.
  • Keating, A.F., Rajapaksa K., Sipes, I.G. and Hoyer P.B. (2008b) Effect of CYP2E1 gene deletion in mice on expression of microsomal epoxide hydrolase in response to VCD exposure. Toxicol Sci 105:351–359.
  • Keating, A.F., Mark C.J., Sen, N., Sipes, I.G. and Hoyer, P.B. (2009) Effect of phosphatidylinositol-3 kinase inhibition on ovotoxicity caused by 4-vinylcyclohexene diepoxide and 7, 12-dimethylbenz[a]anthracene in neonatal rat ovaries. Toxicol Appl Pharmacol 241:127–134.
  • Keating, A.F., Sen, N., Sipes, I.G. and Hoyer, P.B. (2010) Dual protective role for glutathione-S-transferase class pi against VCD-induced ovotoxicity in the rat ovary. Toxicol Appl Pharmacol 247:71–75.
  • Keating, A.F., Fernandez, S.M., Mark-Kappeler, C.J., Sen, N., Sipes, I.G. and Hoyer P.B. (2011) Inhibition of PI3K signaling pathway members by the ovotoxicant 4-vinylcyclohexene diepoxide in rats. Biol Reprod 84:743–751.
  • Liu, K., Rajareddy, S., Liu, L., Jagarlamundi, K., Boman, K., Selstam, G., (2006) Control of mammalian oocyte growth and early follicular development by the oocyte PI3K pathway: new roles for an old timer. Dev Biol 299:1–11.
  • Mark-Kappeler, C.J., Sen, N., Lukefahr, A., McKee, L., Sipes, I.G., Konhilas, J., (2011) Inhibition of ovarian KIT phosphorylation by the ovotoxicant 4-vinylcyclohexene diepoxide in rats. Biol Reprod Jun 15. [Epub ahead of print].
  • Marshall, C.J. (1995) Specificity of receptor tyrosine kinase signaliing: transient versus sustained extracellular signal-related kinase activation. Cell 80:179–185.
  • Mattison D.R., and Thorgeirsson, S.S. (1979) Ovarian arly hydrocarbon hydroxylase activity and primordial oocyte toxicity of polycyclic aromatic hydrocarbons in mice. Cancer Res 39:3471–3475.
  • Mattison, D.R., Plowchalk, B.S., Meadows, M.J., Miller, M.M., Malek, A. and London, S. (1989) The effect of smoking on oogenesis, fertilization, and implantation. Semin Reprod Endocrinol 7:291–304.
  • NTP (1986) Toxicology and carcinogenesis studies of 4-vinylcyclohexene (CAS No. 100-40-3) in F344//N rats and B6C23F1 mice (gavage studies) Tech. Report No. TR-303. Research Triangle Park, NC USA: National Toxicology Program.
  • NTP (1989) Toxicology and carcinogenesis studies of 4-vinylcyclohexne diepoxide (CAS No. 106-87-6) in F344//N rats and B6C3F1 mice (dermal studies). Tech. Report No. TR-362. Research Triangle Park, NC USA: National Toxicology Program.
  • Ogawa, M., Matsuzaki, Y., Nishikawa, S., Hayahi, S.I., Kunisada, T., Sudo, T., (1991) Expression and function of c-kit in hemopoietic progenitor cells. J Exp Med 174:63–71.
  • Packer, A., Hsu, Y., Besmer, P. and Bachvarova, R. (1994) The ligand of the c-kit receptor promotes oocyte growth. Dev Biol 161:194–205.
  • Parrott, J.A. and Skinner, M.K. (1999) Kit-ligand//stem cell factor induces primordial follicle development and initiates folliculogenesis. Endocrinol 140:4262–4271.
  • Rajapaksa, K.S., Cannady, E.A., Sipes, I.G. and Hoyer, P.B. (2007) Involvement of CYP2E1 enzyme in ovotoxicity caused by 4-vinylcyclohexene and its metabolites. Toxicol Appl Pharmacol 221:215–221.
  • Reddy, P., Shen, L., Ren, C., Boman, K., Lundin, E., Ottander, U., (2005) Activation of Akt (PKB) and suppression of FKHRL1 in mouse and rat oocytes by stem cell factor during follicular activation and development. Dev Biol 281:160–170.
  • Reed, J. (1997) Bcl-2 family proteins: regulators of apoptosis and chemoresistance in hematologic malignancies. Semin Hematol 34:p97–19.
  • Smith, B.J., Mattison, D.R. and Sipes, I.G. (1990) The role of epoxidation in 4-vinylcyclohexene-induced ovarian toxicity. Toxicol Appl Pharmacol 105:372–381.
  • Sobrinho, L.G., Levine, R.A., and DeConti, R.C. (1971) Amenorrhea in patients with Hodgkin's disease treated with antineoplastic agents. Amer J Obstet Gynecol 109:135–139.
  • Springer, L.N., McAsey, M.E., Flaws, J.A., Tilly, J.L., Sipes, I.G. and Hoyer, P.B. (1996) Involvement of apopotosis in 4-vinylcyclohexene diepoxide-induced ovotoxicity in rats. Toxicol Appl Phrmacol 139:394–401.
  • Sowers, M.F.R. and LaPietra, M.T. (1995) Menopause: Its epidemiology and potential association with chronic diseases Epidemiol Rev 17:287–302.
  • Vanderhyden, B.C. (2005) Loss of ovarian function and the risk of ovarian cancer. Cell Tiss Res 322:117–124.
  • Waring, S.C., Rocca, W.A., Petersen, R.C., O'Brien, P.C., Tangalos, E.G. and Kokmen, E. (1999) Postmenopausal estrogen replacement therapy and risk of AD: A population-based study. Neruol 52:965–970.
  • Wyllie, A.H., Kerr, J.F.R. and Currie, A.R. (1980) Cell death: the significance of apoptosis. Int Rev Cytol 68:251–305.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.